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Abstract
Nanosilver is the most popular and most studied nanomaterial, however, a family of
nanomaterials is rapidly enlarging. They are used in various branches of industry and
everyday life. In medicine new nanomaterials can be used either alone or in combi‐
nation with other “classical” drugs, e.g. cytostatic drugs or antibiotics. They can be
also used as diagnostic agents. A development of nanoparticles has led to a new
combination of diagnostic and therapy - theranostic. Size of a particle makes a
difference not only between bulk material and nanomaterial, but also in their
properties and toxicity. Nanomaterials can have beneficial properties, but can also be
toxic. New issues concerning nanomaterials arise - an industrial exposure and
environmental pollution. They can enter human body in various ways. Cellular
mechanisms of nanomaterial toxicity comprise mainly a generation of reactive oxygen
species and genotoxicity. The differences between toxicity of fine particles and
nanoparticles have led to an origin of a new branch of science, nanotoxicology.
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1. Introduction
Nanoparticles can be of various origin: natural, incidental, or manufactured. Natural nano‐
particles can be met in fumes or smoke (e.g., carbon black). A fast-growing branch of science,
nanotechnology has led to a development of a variety of newly engineered nanoparticles. As
their use each day becomes broader, the proper evaluation of their toxicity becomes an urgent
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must. Properties of nanomaterials change as their size goes down approaching a nanoscale.
As properties of a bulk form and nanoparticles differ, so we must know if the toxicity also
changes.
2. Nanomaterials used in medicine
When one says “nanoparticle” or “nanomaterial,” the first association usually is nanosilver. It
was the first nanomaterial introduced into medicine due to its antibacterial properties.
Nanosilver has a broad spectrum of both medical and paramedical applications. It is used as
an antibacterial addition to wound dressings and ointments used to protect from infection
wounds, burns, ulcers, and pemphigus. Nanosilver is also applied to cover the surface of
surgical threads, tools, and catheters introduced into veins. Medical protective clothes, gloves,
bed clothes, mattresses, syringes, respiratory tubes, and masks also may contain nanosilver to
reduce the risk of infection. Nanosilver is also used in orthopedics to cover the surface of
various implants and as a component of bone cement to prevent a development of bacterial
infection which in orthopedics may be very dangerous and difficult to treat. Nanosilver is also
used in production of a variety of drug and food packings. Zinc oxide (ZnO) and magnesium
oxide (MgO) nanoparticles also have antibacterial properties and are used as an additive to
food packing [1-3].
Magnetic nanoparticles comprise a next group of medical applications. They are a well-known
diagnostic tool used as magnetic resonance imaging contrast comprising iron oxide nanopar‐
ticles or nanoparticles with iron core. Calcium phosphate nanoparticles doped with a near-
infrared dye for optical imaging, fluorophore, have been tested for in vivo diagnostic of human
breast cancer.
A development of new nanoparticles has led to a development of a new combination of
diagnostic and therapy, theranostic. The simplest explanation of this new term is an identifi‐
cation of diseased tissues or cells and delivery of a medicine or a therapy (e.g., heating) to this
very site of pathology. A gold-silica nanoparticle system for optical imaging and photothermal
ablation has been developed [4-6].
Superparamagnetic iron oxide nanoparticles (SPIONs) and ultra-small superparamagnetic
iron oxide (USPIO) can be used for targeted drug delivery [7]. Another kind of intensively
studied nanomaterials are mesoporous silica nanoparticles. They may be used for high drug
or imaging agent loading. “Cornell dots” are the first silica-based diagnostic nanoparticles
approved for human clinical trials. Gold nanoparticles can have various medical applications
such as improving efficacy of high-resolution ultrasound imaging, photothermal therapy, and
photothermal release of DNA cargo upon laser irradiation. They have been also shown to pose
antibacterial activities. Quantum dots constitute another class of nanoparticles. They can be
extremely small, typically having only few nanometers. They are usually composed of heavy
metals such as lead or cadmium. Scientists hope to employ them in sophisticated multimodal
imaging techniques [8]. Nanogels, dendrimers, and liposomes are the other classes of nano‐
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materials. They can be used for controlled drug delivery. Cell growth scaffolds may be another
application of these classes of nanomaterials [8].
3. Entry portal of nanomaterials into the human body
Various nanomaterials can be used in different ways. Many nanomaterials are used as drug
carriers or imaging agents with an intravenous entrance into the human body. This gateway
for nanoparticles can be well controlled. This way of introducing nanoparticles into the human
body allows for their easy distribution to all organs. The nanoparticles only have to be able to
cross the barrier of blood vessel wall.
Absorption through the skin is another way in which nanoparticles can enter the human
organism. The skin is the largest organ of the human body, reaching above 10 % body mass.
It gives a large area of contact with the external environment, approximately 1,73 m2. Skin
contact with nanomaterials may be due to various reasons, occupational contact in industry,
medical applications, and a still-growing amount of cosmetics containing nanoparticles and
clothes with nanoparticles, e.g., sock containing nanosilver to reduce odors. Cosmetics and
products for everyday hygiene like soaps, shampoos, gels, creams, and deodorants also may
contain nanosilver. This nanoparticle is not the only one the skin may be exposed to. Sunscreens
protecting the skin against UV radiation contain titanium dioxide (TiO2) and ZnO nanoparti‐
cles. The nanoform of these two oxides is more often used due to its transparent form which
is more acceptable by customers.
Often nanoparticles, mainly nanosilver, are used for treatment of burns, wounds, or ulcers.
Although they are intended to be used topically to prevent infections, a damaged skin makes
their penetration into the body easier. There are four pathways the chemical compounds can
penetrate across the skin: intracellular, transcellular, and two of transappendageal through
sweat glands and hair follicles. The way of penetration depends on physicochemical properties
of nanoparticles. Many other factors can influence the extent of dermal uptake. They can be
roughly divided into two groups, caused by a condition of the skin and by external factors.
The anatomical side resulting in differences of epidermis thickness, a skin barrier integrity and
the presence of wounds or scratches, and skin diseases like allergic or irritant contact derma‐
titis, atopic eczema, and psoriasis compose the first group. The external factors include the
contaminated skin surface, irritant detergent and chemicals, mechanical flexion, and exposure
to heat, infrared, or UV radiation. They can increase the skin absorption of nanoparticles [8].
Metallic nanoparticles smaller than 10 nm have been shown to penetrate epidermal layers [3,
9]. Most dermal exposure studies indicate that TiO2 does not penetrate the stratum corneum
[10]. Carbon nanoparticles comprising single-walled and multiwalled carbon nanotubes and
fullerenes have a large variety of applications. Fullerenes have been shown to penetrate flexed
but not unflexed skin [10]. Unrefined single-walled carbon nanotubes have been shown to
exert negative effects on cultured skin cells, increasing generation of free radicals and causing
ultrastructural and morphological changes in keratinocytes. These carbon nanoparticles
induced also cellular apoptosis and necrosis response. The surface area of carbon nanotubes
is the best predictor of their negative effects [10].
Medical Aspects of Nanomaterial Toxicity
http://dx.doi.org/10.5772/60956
163
Quantum dots also can penetrate the intact skin. This fact is important in an aspect of occu‐
pationally relevant skin contact. A surface coating of quantum dots does not influence their
penetration into the skin, but is responsible for a magnitude of toxic effects on skin cells
including cytotoxicity and immunotoxicity [10]. Nanosilver which is contained in various
dressings may influence both keratinocytes and fibroblasts. The latter are more sensitive to
nanosilver than keratinocytes [10]. Gold nanoparticles can penetrate into the skin. This ability
is size dependent. The smaller the nanoparticle, the deeper it can penetrate. Citrate/gold
nanoparticles can be toxic to human dermal fibroblasts [11]. Iron oxide nanoparticles can
penetrate into the skin. They can be rapidly endocytosed by cultured human fibroblasts and
disrupt their function [10].
While discussing skin penetration of nanoparticles, another question arises. Can nanoparticles
cross the skin barrier and be distributed by blood to other organs? Scientists mainly focus their
attention on evaluation of nanoparticle penetration into either usually porcine skin or culture
skin keratinocytes or fibroblasts. If some nanoparticles can penetrate into deeper layers of the
skin, the abovementioned question requires an urgent answer.
Inhalation constitutes the next entry portal of nanomaterials into the human body. This
gateway is very important in a case of occupational exposure to nanoparticles. Lansiedel et al.
applied a new method for evaluation of toxicity of inhaled nanoparticles, a short-time
inhalation study (STIS) instead of a 90-day rodent inhalation study. Nanoparticles and
microscale zinc oxide were evaluated in this study. Among tested materials, only polyacrylate-
coated silica and both forms of ZnO were found in extrapulmonary organs. The first was found
in the spleen, whereas both forms of ZnO elicited necrosis on the olfactory epithelium. Five
materials – coated nano TiO2, nano-CeO2, Al-doped nano-CeO2, and both forms of ZnO –
evoked transient, dose-dependent pulmonary inflammation. The results of this study enabled
to classify studied materials into three groups. Nano-BaSO4, nano-SiO2, four types of surface
coated silica – SiO2-polyacrylate, SiO2-PEG, SiO2-phosphate, and SiO2-amino – nano-ZrO2,
ZrO2 TOTA, and ZrO2-acrylate were of low toxic potency. The group of medium toxic potency
had only one studied nanoparticle, non-coated amorphous silica (naked silica). The third group
of higher toxic potency comprised coated nano-TiO2, nano-CeO2, Al-doped nano-CeO2,
microscale ZnO, and coated nano-ZnO [11]. ZnO nanoparticles induced collagen formation 4
weeks after instillation [12].
Titanium dioxide has gained much attention in recent years. It can be used in a form of either
fine particles or nanoparticles. TiO2 fine particles have been considered as poorly soluble, low-
toxicity particles. Due to their properties, they have been used as a “negative control” in many
toxicological studies. A long-term, 2 years, study with high-dosed TiO2 revealed that fine
particles of TiO2 might cause lung tumors in rats. The International Agency for Research on
Cancer (IARC) has classified TiO2 as possibly carcinogenic to humans (carcinogen group 2B).
With this fact arises a question: Can the results of studies of larger particles be automatically
transferred to nanoparticles? Some studies have shown that TiO2 are more toxic than TiO2 fine
particles. Although TiO2 nanoparticles were shown not to penetrate through the skin, the
effects of inhalation of these nanoparticles seem to require further studies [11].
Gastrointestinal absorption is another important route nanoparticles may enter the human
body. This way is important for nanoparticles which are allowed as “food contact substances”
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and which may come in contact with drinking water, e.g., nanosilver present in water filters
or water purifiers.
The most common way of uptake for both microparticles and nanoparticles in gut is endocy‐
tosis by M-cell in Peyer’s patches. Once nanoparticle enters the blood stream, they are
distributed throughout the body. Nanoparticles can pass through barriers of the body and
accumulate in certain organs. Small gold nanoparticles (10 nm) were found to accumulate in
the liver, spleen, kidney, lungs, brain, and reproductive system, whereas larger ones (50–100
nm) and 250 nm were found only in the blood, liver, and spleen [13]. The size of nanoparticles
is an important factor in determining their blood circulation time and places of deposition in
an organism [14]. Nanoparticles entering the gastrointestinal tract are exposed to a wide range
of pH. Hydrochloric acid secreted in the stomach has been shown to influence dissolution of
silver nanoparticles. In these conditions, silver ions are generated from silver nanoparticles.
As the ability of silver particles to cross the gut epithelium is limited, it seems that the main
route of silver uptake from gastrointestinal tract is ion transport. Silver ions may be transported
by mechanism responsible for transport of sodium and copper ions [1,15].
Biological fluids present a wide spectrum of chemical conditions. They can influence nano‐
particles in various ways and can cause their agglomeration, changing their properties,
penetration potency, and also toxicity. The fact that some in vivo conditions may change the
particle size must be taken into consideration while evaluating the toxicity of nanomaterials.
It may lead to a conclusion that in some conditions, not a particle size but a size of agglomerate
may determine the properties of nanoparticles and consequently their toxicity [16].
Sometimes nanoparticles can be administered using the intraocular and intranasal routes
which have not been widely studied. Nanosilver can be used in some intrauterine devices,
creating another plausible gateway for nanoparticles.
Nanomaterials can be used as drug carriers and enhancers. The term “drugs” should be widely
understood. They can be of classical chemical nature. Nanoparticles can improve dissolution
and solubility of poorly soluble drugs and successful delivery of hydrophobic drugs, increas‐
ing their concentration at targeted tissues. Nanoparticles may also be used for delivery of drugs
into specific cell compartment. This application of nanomaterials may comprise various routes
of administration, not only intravenous.
Nanoscale changes structure-activity relationship of complex nanoparticles. The use of
nanoformulations of drugs allows them to pass some biological barriers which for classical
drug forms are not transferrable. The blood-brain barrier may be a prominent example. The
complex of drug on a nanoporous silica gives a tool for controlling the release of drug at its
side of destination and action [17]. As a progress of pharmacology and nanotechnology enables
to create nanoparticles carrying various drugs, an important question arises. What is respon‐
sible for specific side effects, a carrier or a cargo? This approach creates the novel branch of
science – nanotoxicology.
The efficacy of nanoparticles relies on a variety of their modifications and functionalities. This
advantage creates a variety of tasks for nanotoxicology to evaluate the safety/toxicity profile
of each modification. The study of Landsiedel et al. shows that modifications of nanoparticles
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may change their toxicity. Those modifications can alter hydrophobicity and isoelectric points
of particles. Various nanoparticles can have different abilities to agglomerate in specific
biological conditions that may have an important influence on their toxicity [14,18].
4. Toxicity of nanoparticles
The size of nanoparticles of the same chemical compound or the same chemical element may
vary in a wide range from a few nm to about 100 nm. Results of studies concerning nanopar‐
ticles of the same chemical nature can give various results depending on the size of used
nanoparticles. A kind of exposure resulting in a specific way of possible absorption is another
factor influencing the results of toxicological studies. TiO2 which is thought not to cross the
skin barrier in humans may induce lung tumors in rats when inhaled in high doses for a long
time. TiO2 nanoparticles may be absorbed both from the lungs and gastrointestinal tract.
However, the rate of absorption appears to be low. Studies with intravenous administration
of TiO2 indicate that these nanoparticles can induce pathological lesions of the liver, spleen,
kidney, and brain. These effects may be attributed to very high doses of TiO2 nanoparticles
used in this study [10]. The use of TiO2 is widespread. It may be used even as a white color
food additive. It is difficult to estimate how much of total TiO2 used is the form of larger, fine
particles and how much in the form of nanoparticles. The difference in toxicity of TiO2 fine
particles and nanoparticles is reflected in allowances of occupational exposure. In the USA,
the threshold limit value of TiO2 fine particles (total dust) is assigned as 10 mg/m3 as time-
weighted average (TWA) for an 8-hour daily work time 5 days per week. That value was
established by the American Conference of Governmental Industrial Hygienists (ACGIH). The
regulation of the Occupational Safety and Health Administration (OSHA) is 15 mg/m3. The US
National Institute for Occupational Safety and Health (NIOSH) proposed a recommended
exposure limit (REL) for TiO2 nanoparticles of 0.3 mg/m3, being 10 times lower than REL for
TiO2 fine particles. In Japan, TWA for TiO2 nanoparticles is 1.2 mg/m3. The fact that the same
recommendation in the USA and Japan differs four times indicates that further studies
concerning safety limits of exposure to TiO2 nanoparticles are required [10].
The skin is a site where the first side effect of nanomaterial was observed. Silver and nanosilver
used as antibacterial agent when overdosed caused an irreversible pigmentation of skin termed
argyria or argyrosis. In these patients, silver deposits form usually in skin regions exposed to
light. The silver deposits are usually collocated with sulfur and selenium. Silver is usually
bound to protein thiol groups or selenium in the case of selenoproteins. Both sulfides and
selenides have a high binding affinity for silver, causing its uptake from biological fluids. Silver
bound to these chemical groups is easily exchangeable and has significant biomolecular
mobility. If silver complexes with thiol groups are located in the skin or near-skin region, silver
can be easily reduced by visible or UV light to metallic nanosilver particles, resulting in an
immobilization of silver nanoparticles in the skin. This process puts new light on a pathogen‐
esis of a very old side effect of treatment with various drugs containing silver, argyria. It also
explains why this side effect is usually located in skin regions exposed to light [15].
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Animal experiments with topical administration of colloid nanosilver showed both acute and
chronic dermal toxicity. It was also observed that nanosilver could penetrate from the skin to
the blood and accumulate in the liver and spleen, causing their mild damage detected in
histopathological examination [19]. The fact that nanosilver can cross the skin barrier makes
us look closer and with a greater attention on results of in vitro studies showing nanosilver
toxicity to various cultured cell lines. Nanosilver has been shown to be toxic to peripheral
blood mononuclear cells, human alveolar epithelial cells and alveolar macrophages, rat
hepatocytes, and mouse germline cells [17]. These results indicate that the safety of a still-
increasing use of nanosilver should be better monitored.
In biological fluids, proteins can associate with nanoparticles. The competing of proteins for
the nanoparticle surface leads to a generation of protein “corona” surrounding the nanopar‐
ticle. This process can take place in the blood. Not only albumins and fibrinogen can compete
to create “corona” but also lipoproteins. Such an association alters nanoparticle characteristics
and their biological properties. Some nanoparticles associated with apolipoprotein E can cross
the blood-brain barrier. This modification giving some nanomaterials new important biolog‐
ical property has a potential significance for a development of new neurotherapies as well as
for neurotoxicity [18,19].
In humans, nanosilver was shown to inhibit the extrinsic coagulation pathway evaluated by
activated partial thromboplastin time (APTT) [20]. In animal experimental model, nanosilver
decreased platelet activation [21]. Nanosilver can cross the blood-brain barrier and accumulate
in the brain, causing necrosis and neuronal degeneration [22]. In a study of Ahamed et al. [23],
nanosilver particles elicited genotoxicity on mouse embryonic fibroblasts. This was caused by
both polysaccharide-coated and uncoated nanosilver particles. Nanosilver was also shown to
accumulate in the testis [24].
Detailed nanotoxicological studies dealing with mammalian reproductive tissues and gametes
have yet to be carried out. A very limited group of nanomaterials have been shown as
biocompatible with mammalian sperm: magnetic iron nanoparticles, a specific type of
CdSe/ZnS quantum dots, halloysite clay nanotubes, and commercial nanopolymer-based
transfectants [25]. A group of nanomaterials biocompatible with mammalian embryo is smaller
and comprises chitosan, CdSe/ZnS quantum dots, and externally applied polystyrene nano‐
particles.
Results of studies of sperm toxicities of nanogold remain highly contradictory [25]. Some of
them reported that nanogold elicited spermatoxicity [18].
Nanocopper was shown to reduce in a dose-depended manner cell viability of mouse testis
Leydig cells. In vitro studies of TiO2 nanoparticles and ZnO nanoparticles demonstrated a
dose-dependent sperm DNA damage in human spermatozoa. Various studies evaluating the
influence of TiO2 nanoparticles on mammalian ovarian cells gave contradictory effects [26].
Various nanoparticles can also influence the endocrine system. In animal models, TiO2
nanoparticles and CdTe/ZnTe quantum dots conjugated with transferrin could alter serum
levels of sex hormones and gonadotropins [26].
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Nanoparticles can easily cross the placental barrier and enter a fetus. The animal experiments
showed that fullerene nanoparticles were traced in embryos and at higher doses caused
significant toxicity and death [27]. TiO2 was shown to transfer from pregnant mice to their
offsprings, affecting the central nervous system and genitals [28]. The results of abovemen‐
tioned studies raise a question about the risk of nanoparticle exposure to pregnant women.
Nanoparticles can influence the immune system. They were shown to induce inflammatory
response. ZnO nanoparticles can exert their activity on immune cells through three mecha‐
nisms. Promoting antigen uptake by antigen-presenting cells is the first one. Targeting to
specific cells like dendritic cells, Langerhans cells, or macrophages is the second mode. The
third one is immunopotentation and modulation of activity of antigen-presenting cells through
receptors of innate immune system [29]. ZnO nanoparticles have been found to induce
toxicities particularly in the immune cells as these nanoparticles are specifically found to be
internalized in these cells [29]. Nanoparticles can also act as haptens and modify protein
structures, raising their potential for autoimmune effects [18].
5. Cellular mechanisms of nanoparticles toxicity
In this chapter, the cellular mechanisms of nanomaterials toxicity will be only very briefly
mentioned as they are discussed in detail in other chapters of this book.
5.1. Reactive oxygen species production
Reactive oxygen species (ROS) constitute a pool of reactive species of molecular oxygen,
previously termed free radicals, including superoxide anion (O2⋅ -), hydroxyl radical (OH⋅),
hydrogen peroxide (H2O2), singlet oxygen (1O2), and hypochlorous acid (HOCl). Most of them
are produced via electron transport chain in the mitochondria. ROS are generated intrinsically
or extrinsically within the cell. ROS production is widely used in cell signaling, regulation, and
homeostasis [14,30,31].
Nanoparticles entering the cell interact with mitochondria and other subcellular organelles
increasing ROS production. Various nanomaterials of various sizes can disturb mitochondrial
function. ZnO nanoparticles can generate Zn2+ ions interrupting charge balance in electron
transport chain in the mitochondria and triggering ROS formation. Semiconductor nanoma‐
terials can elicit an excited energy state, leading to the generation of O2⋅ -. This ROS is capable
of damaging cellular macromolecules or interrupting cell signaling, leading to cell dysfunction.
It also can cause further generation of other ROS. Some nanoparticles can interact between one
another. Excited CdSe quantum dots are capable of injecting electrons into TiO2 [32]. It was
observed that photoactivation of TiO2 could also generate O2⋅ - and OH⋅ radicals [31]. This fact
seems to be important considering the still-growing use of TiO2 nanoparticles. An increased
generation of ROS causes further intracellular disorders [31].
Nanosilver has been observed to significantly decrease incorporation of selenium into
selenoproteins constituting enzymes engaged in antioxidant protection such as glutathione
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peroxidase, thioredoxin reductase, or methionine sulfide reductase [1,21]. Nanomaterials via
increased ROS generation lead to a glutathione depletion. Glutathione is a main intracellular
antioxidant. This depletion may significantly affect cellular metabolism causing mitochondrial
dysfunction and ATP depletion [30].
Generation of lipid peroxides is a next effect of increased ROS generation. Various nanoma‐
terials have been reported to generate lipid peroxides and resultant cell membrane damage.
Nanosilver can induce both mitochondrial damage and mitochondrial-dependent apoptotic
pathway [30].
The destruction of cell membrane can cause a membrane leakage of lactate dehydrogenase.
The assay for evaluating the extracellular activity of this enzyme is most commonly used for
membrane leakage testing. Monitoring lactate dehydrogenase activity can be a useful tool for
evaluation of toxicity of nanomaterials [30].
5.2. Genotoxicity
Genotoxicity is caused by agents interacting with DNA and other compounds controlling the
integrity  of  the  genetic  material  and includes  DNA strand breaks,  point  mutations,  ad‐
ducts, and structural or numerical chromosomal changes. Nanosilver was the first nanoma‐
terial reported to cause DNA damage. This effect was observed in various cells. Ma et al. [33]
observed that nanosilver caused DNA damage accompanied by cell cycle arrest in human
dermal fibroblasts.  Hackenberg et al.  [34] demonstrated genotoxic effect of nanosilver in
human mesenchymal cells. However, to elucidate these effects, nanosilver had to be used at
a significantly higher concentration as compared to antimicrobial effective levels. In mamma‐
lian cells, nanosilver caused an increase of p53 protein expression and Rad51 expression. The
latter is a double-strand break repair protein. Nanosilver also induced apoptosis. The strength
of this genotoxic influence of nanosilver depended on a kind of nanosilver particles used.
Polysaccharide-coated  nanosilver  particles  exhibited  more  severe  DNA  damage  than
uncoated [23].
Nanosilver can cause DNA damage mainly by two mechanisms. The augmentation of ROS
generation by nanosilver may result in an oxidative damage of both proteins and DNA.
Increased oxidation may lead to a transformation of nanosilver to silver ions Ag+ which can
bind to guanine N7 atom. While increasing concentration, they can also bind to adenine N7
atom. Silver ions can also induce G1 phase cell cycle arrest and, at a higher concentration, a
complete arrest in the S phase [35]. Nanosilver was also reported to induce formation of
micronuclei due to the disruption of genetic material division. Formation of micronuclei is
used to measure a potential of genotoxicity due to its sensitive response to various abnormal‐
ities in chromosomal segregation [36].
A study of Ivask et al. [36] revealed that nanosilver and graphene oxide nanoparticles shifted
a melting point, triggering an early onset of DNA melting. These nanoparticles could also
change a DNA hydrodynamic size. These observations may indicate novel mechanisms of
nanoparticle genotoxicity. Very thin (1.4 nm) gold nanostructures can intercalate with DNA,
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leading to cell death in human cancer cells [37]. SiO2 nanoparticles can enter into the nucleus
and localize in the nucleoplasm. However, they are not considered as carcinogenic [37,38].
Lan et al. observed that TiO2 nanoparticles and carbon black nanoparticles could damage DNA
via oxidative stress in human cells. These authors reported that eukaryotes, especially
mammalian cells, were more sensitive to the genotoxicity than prokaryotes [39]. NIOSH has
classified TiO2 as carcinogenic. Interesting results were obtained by Darnes et al. who observed
that genotoxicity of carbon nanotubes increased with their width [40].
CdS quantum dots are semiconductor nanocrystals with an increasing use. Their potential
toxicity has become a health concern. A study of Munari et al. [41] indicated that this nano‐
material exhibited a concentration-independent genotoxicity in rainbow trout cell line RTG-2.
In the same experiment, nanosized Ag2S showed neither cytotoxicity nor genotoxicity.
While evaluating and comparing results of studies on genotoxicity of nanomaterials, an
influence of several factors should be considered. The conflicting results of various studies
may be caused by two groups of factors. The first one deals with nanoparticles and comprises
variation of size of the nanoparticles, variations of size of distribution, various purities of the
nanomaterials with the same average size of nanoparticles, differences of their coatings,
differences of crystal structure of the types of nanomaterials, differences of size of aggregates
in solution or medium, and different concentrations of nanomaterials used in assay test. The
second group comprises testing conditions such as cell number, cell culture plate format and
volume of treatment medium on the plate, and differences in assays [42,43].
5.3. Activation of inflammatory pathways
Nanoparticles can influence macrophages and neutrophils eliciting an inflammatory response.
These cells try to destroy foreign objects, usually microbial pathogens, inducing enormous
ROS generation. Nanoparticles are also treated by macrophages and neutrophils as something
foreign and these cells try to get rid of them, increasing production of ROS. It leads to an
induction of inflammation [20,31]. An augmented ROS generation can increase the inflamma‐
tory response by activation of expression of nuclear factor kappa B (NFκB). It is one of the
major transcriptional factors. It plays an important role in cell survival, differentiation, and
proliferation. It is also involved in growth and development of the immune system. NFκB is
heavily involved in the initiation of inflammatory response [14].
Many nanoparticles have also been reported to induce inflammatory response through
activation of expression of tumor necrosis factor alfa (TNF-α). Nanoparticles can also lead to
an increased expression of other proinflammatory cytokines such as interleukins 2, 6, 8, and
10 (IL-2, IL-6, IL-8, and IL-10) [14,20].
ROS generated by nanoparticles can be either bound to the nanoparticle surface or generated
as free entities in surrounding aqueous suspension. An antioxidant enzyme, glutathione
reductase, can reduce metal nanoparticles into intermediates potentiating the ROS generation.
In this way, nanoparticles can not only increase the generation of ROS but also interfere with
the antioxidant protection mechanisms [31].
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Macrophages and neutrophils can internalize nanoparticles. The consequence of this process
is an activation of these cells, elucidation of inflammatory response, and even cytotoxic effects
of nanoparticles on these cells [20,31].
Pulmonary inflammation seems to be the most prominent inflammatory response generated
by nanoparticles. SiO2 and TiO2 nanoparticles have been reported to induce this response,
whereas occupational exposure to metal nanoparticles such as Fe, Mn, Si, Cr, and Ni present
in welding fumes may elicit both inflammation and fibrogenic response [31].
6. Conclusions
A family of nanomaterials is rapidly enlarging. The spectrum of the use of nanomaterials is
getting wider, comprising medical, paramedical, and everyday use. In medicine, they can be
used either alone or in combination with other “classical” compounds, e.g., cytostatic drugs
or antibiotics. The latter situation uses their ability to penetrate to certain cells or intracellular
compartments. Nanoparticles are also introduced as valuable tools improving existing
diagnostic methods, e.g., MNR.
New issues concerning nanomaterials arise, an industrial exposure and environmental
pollution. Nanoparticles are being discovered in already known pollutions like diesel exhaust
or welding fumes. These “unwanted” nanoparticles put new light on the toxicological
mechanisms of already known pollutions. It also makes us look at pollutions in macroscale,
microscale, and nanoscale. A rapidly developing branch of electronics also creates new sources
of possible occupational exposure hazard. This situation creates new challenges for both
classical toxicology and nanotoxicology. Centuries ago, Paracelsus said, “everything is a
poison and nothing is a poison, it is only a matter of a dose.” In a case of nanomaterials, it is a
case of both dose and particle size [1].
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